NCT02047526撤回不适用
A Non-interventional, Prospective Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- AstraZeneca
- 主要终点
- HF related Hospitalization and hospital visits
研究概览
简要总结
This non-interventional, prospective, multi-centric, cross-sectional study is aimed to observe clinical practice in India in managing Heart Failure patients & to check one year outcome in HF patients. A total of 5 visits will be conducted during the study. There will be a baseline visit followed by four follow-up visits to assess the outcomes
详细描述
A non-interventional, prospective study to evaluate the clinical epidemiology of patients with Heart Failure (HF) in India
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Provision of subject informed consent
- •Female or male aged 18 years and over
- •All patients with Dyspnea and/or signs of systemic congestion
排除标准
- •Subjects with Current Acute Coronary Syndrome
- •Absence of cardiac disease/structural heart disease
结局指标
主要结局
HF related Hospitalization and hospital visits
时间窗: 1 year
Cardiovascular and all cause mortality
时间窗: 1 year
Cardiovascular hospitalization rates and Length of stay
时间窗: 1 year
Change in Minnesota Living with Heart Failure Questionnaire scores.
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaOvarian CancerNCT03471572AstraZeneca240
Unknown
不适用
Assessment of Heparin Binding Protein for the Prediction of Severe SepsisSepsis With Acute Organ DysfunctionSepsisSeptic ShockNCT03113721Axis Shield Diagnostics Ltd571
已完成
不适用
Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)EpilepsyNCT01532726Bial - Portela C S.A.56
已完成
不适用
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron OverloadChronic Iron OverloadNCT05440487Novartis Pharmaceuticals489
招募中
不适用
Registry Study in MSI/dMMR Solid TumorsDMMR CancerMSI-HSolid TumorNCT06004713Peking University Cancer Hospital & Institute190